ClinConnect ClinConnect Logo
Search / Trial NCT06823999

Prevention and Treatment for Bruises in Patients with Ischemic Stroke

Launched by CHIAYI CHRISTIAN HOSPITAL · Feb 11, 2025

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Stroke Bruises Skin Lesions Vitamin C Bleeding

ClinConnect Summary

This clinical trial is studying whether vitamin C injections can help prevent and treat bruises in patients who have had an ischemic stroke, which is a type of stroke caused by a blockage in the blood vessels in the brain. Bruises can be common among stroke patients and may lead to additional health risks, such as infections. The researchers want to find out if giving vitamin C shortly after a stroke can reduce the number and severity of bruises, as well as improve overall recovery.

To be eligible for the study, participants must be between 20 and 85 years old and diagnosed with an ischemic stroke confirmed by brain imaging. Those with certain health conditions, such as cancer, kidney disease, or blood disorders, will not be included. If accepted into the trial, participants will receive either vitamin C injections or a saline solution (a harmless saltwater solution) for four days, and their skin condition will be monitored during and after their hospital stay. Ultimately, this study aims to improve the quality of life for stroke patients by addressing not just their recovery from the stroke itself, but also the secondary issues like bruising.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ischemic stroke patients.
  • Aged 20 to 85 years.
  • Exclusion Criteria:
  • o Cancer patients undergoing chemotherapy.
  • End-stage renal disease patients receiving hemodialysis.
  • Patients undergoing immunosuppressive therapy.
  • Patients with coagulation disorders.
  • Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency (favism).
  • Patients with thalassemia.
  • Patients who did not sign the consent form.

About Chiayi Christian Hospital

Chiayi Christian Hospital is a leading healthcare institution in Taiwan dedicated to providing comprehensive medical services and advancing clinical research. Established with a mission to enhance patient care through innovative treatments and therapies, the hospital actively engages in clinical trials that focus on a wide array of medical conditions. With a commitment to ethical standards and patient safety, Chiayi Christian Hospital collaborates with healthcare professionals and researchers to contribute to the development of evidence-based practices and improve health outcomes in the community. Their robust research infrastructure and multidisciplinary approach position them as a key player in the advancement of medical science.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported